February 3rd 2023
Newly released safety and efficacy data on Novartis’ secukinumab for hidradenitis suppurativa is published in The Lancet.
February 3rd 2023
February 2nd 2023
The Importance of Maui Derm for the Dermatology Field
January 27th 2023Mona Shahriari, MD, Assistant Clinical Professor of Dermatology at Yale University School of Medicine, and Dermatology Times® editorial advisory board member explains her role in Maui Derm Hawaii 2023, and what the Maui Derm Hawaii conference means to her, and the field of dermatology.